Risk of chronic liver disease in HBsAG and/or anti-HCV-positive renal allograft recipients
Durlik, M.; Gaciong, Z.; Soluch, L.; Walecka-Zielecka, B.; Rancewicz, Z.; Rowińska, D.; Rowiński, W.; Szmidt, J.; Lao, M.
Transplantation Proceedings 28(1): 50-51
1996
ISSN/ISBN: 0041-1345 PMID: 8644327 Document Number: 469436
Document emailed within 1 workday
Related Documents
Antoine, C.; Bedrossian, J.; Binet, I.; Schenmetzeler, C.; Selami, F.; François, A. 1995: Follow-up of renal allograft recipients from HBsAg positive donors. GCIF Transplantation Proceedings 27(2): 1725-1726Durlik, M.; Gaciong, Z.; Soluch, L.; Rowińska, D.; Kozłowska-Boszko, B.; Rowiński, W.; Szmidt, J.; Lao, M. 1996: Results of kidney transplantation in HBsAG and anti-HCV seropositive renal allograft recipients Transplantation Proceedings 28(6): 3459-3460
Palmer, A.; Bewick, M.; Kennedy, L.; Welsh, K.; Taube, D. 1989: Anti-HLA antibodies following the transplantation of highly sensitised renal allograft recipients Transplantation Proceedings 21(1 Pt 1): 766-767
Vincent, F.; Raynal, N.; Francois, A.; Belec, L.; Duboust, A.; Glotz, D.; Bariety, J. 1995: False-positive p24 antigenaemia detected in renal allograft recipients: possible role of rabbit antithymocyte globulins Transplantation Proceedings 27(2): 1738
Rocco, P.; Biceglia, O.; Paceli, M.; Minerva, A.; De Biasio, M.C.; De Crescenzo, O.D.; Forte, G.B. 1996: The peripheral blood lymphocyte subpopulations in chronic anti-HCV-positive liver disease: their significance and correlation with liver function Minerva Gastroenterologica E Dietologica 42(2): 51-55
Dragosics, B.; Pesendorfer, F.; Wewalka, F. 1975: Anti-HBsAg-positive acute hepatitis with a severe disease course Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1353-1356
Harihara, Y.; Kurooka, Y.; Yanagisawa, T.; Kuzuhara, K.; Otsubo, O.; Kumada, H. 1994: Interferon therapy in renal allograft recipients with chronic hepatitis C Transplantation Proceedings 26(4): 2075
Lewandowska, D.; Durlik, M.; Pazik, J.; Lewandowski, Z.; Lao, M.ła. 2003: The influence of lamivudine therapy on the course of chronic hepatitis B in renal allograft recipients Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 15(88): 367-370
Musca, A.; Cordova, C.; Barnaba, V.; Bonavita, M.S.; Levrero, M.; Zaccari, C.; Balsano, F. 1983: HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis Hepato-Gastroenterology 30(1): 3-5
Anand, A.C.; Seth, A.K.; Nagpal, A.; Varma, P.P.; Gadela, S.R.; Baliga, K.V.; Dutta, V.; Chopra, G.S. 2004: Initial experience with ribavirin plus glycyrrhizin in renal allograft recipients with chronic hepatitis C Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 23(6): 226-227
Chuang, W.L.; Chang, W.Y.; Wang, L.Y.; Tsai, J.F.; Hsieh, M.Y.; Chen, S.C.; Chiang, W.; Liu, W.J. 1989: Lymphocyte transformation in patients with HBsAg-positive chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma Journal of the Formosan Medical Association 88(6): 557-561
Sonoda, K.; Meek, A.G.; Strober, S.; Hayashi, R.; Ishimaru, M.; Rapaport, F.T. 1989: Synergistic efficacy of staged total lymphoid irradiation and cyclosporine in the preoperative preparation of high-risk hyperimmunized canine renal allograft recipients Transplantation Proceedings 21(1 Pt 1): 1116-1117
Sturgiss, S.N.; Davison, J.M. 1991: Perinatal outcome in renal allograft recipients: prognostic significance of hypertension and renal function before and during pregnancy Obstetrics and Gynecology 78(4): 573-577
Nassal, M.; Theilmann, L.; Pfaff, E. 1987: Rapid procedure for the detection of hepatitis delta virus RNA in sera of HBsAg-positive and anti-delta-positive patients Arzneimittel-Forschung 37(6): 748-751
Ivanovski, N.; Stojceva-Taneva, O.; Grozdanovski, R.; Boskovska, M.; Drueke, T.B.; Massy, Z.A. 2004: Short-term effect of folic acid supplementation in renal transplant recipients and chronic kidney disease patients with comparable renal function impairment Nephrologie 25(7): 301-303
Etheredge, E.E.; Anderson, C.B. 1978: Serum autoleukocytotoxic activity and the positive cross-match in potential allograft recipients Surgery 83(5): 565-569
Diodati, G.; Pontisso, P.; Pornaro, E.; Stenico, D.; Bonetti, P.; Realdi, G.; Ruol, A. 1987: Chronic HBsAg-negative liver disease. Presence of the markers of hepatitis B virus (HBV) infection and their possible meaning Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 2(3): 195-200
Sengar, D.P.; Couture, R.A.; Lazarovits, A.I.; Jindal, S.L. 1989: Long-term patient and renal allograft survival in HBsAg infection: a recent update Transplantation Proceedings 21(2): 3358-3359
Hussain, Z.; Naqvi, R.; Hashmi, A.; Hafiz, S.; Naqvi, A.; Rizvi, A. 1996: Tuberculosis in renal allograft recipients Transplantation Proceedings 28(3): 1516-1517
Juskowa, J.; Paczek, L.; Barańska, E.; Rancewicz, Z.; Stryjecka-Rowińska, D.; Gradowska, L.; Wyzgał, J.; Senatorski, G.; Cieplak, M. 1996: Lipid peroxidation in renal allograft recipients Transplantation Proceedings 28(6): 3474-3476